BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 36111068)

  • 1. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort.
    Goodrich JA; Walker D; Lin X; Wang H; Lim T; McConnell R; Conti DV; Chatzi L; Setiawan VW
    JHEP Rep; 2022 Oct; 4(10):100550. PubMed ID: 36111068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: A meet-in-the-middle approach.
    Chang CJ; Barr DB; Ryan PB; Panuwet P; Smarr MM; Liu K; Kannan K; Yakimavets V; Tan Y; Ly V; Marsit CJ; Jones DP; Corwin EJ; Dunlop AL; Liang D
    Environ Int; 2022 Jan; 158():106964. PubMed ID: 34735953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease.
    Sen P; Qadri S; Luukkonen PK; Ragnarsdottir O; McGlinchey A; Jäntti S; Juuti A; Arola J; Schlezinger JJ; Webster TF; Orešič M; Yki-Järvinen H; Hyötyläinen T
    J Hepatol; 2022 Feb; 76(2):283-293. PubMed ID: 34627976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach.
    Jin R; McConnell R; Catherine C; Xu S; Walker DI; Stratakis N; Jones DP; Miller GW; Peng C; Conti DV; Vos MB; Chatzi L
    Environ Int; 2020 Jan; 134():105220. PubMed ID: 31744629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
    Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
    Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
    Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
    Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis.
    Alderete TL; Jin R; Walker DI; Valvi D; Chen Z; Jones DP; Peng C; Gilliland FD; Berhane K; Conti DV; Goran MI; Chatzi L
    Environ Int; 2019 May; 126():445-453. PubMed ID: 30844580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of exposure to perfluoroalkyl substances and risk of the acute coronary syndrome: A case-control study in Shijiazhuang Hebei Province.
    Li H; Chen J; Jingchao Lu ; Yang J; Tan Z; Li L; Xiao F; An Z; Ma C; Liu Y; Wang L; Zhang X; Guo H
    Chemosphere; 2023 Feb; 313():137464. PubMed ID: 36495974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Signatures of Youth Exposure to Mixtures of Per- and Polyfluoroalkyl Substances: A Multi-Cohort Study.
    Goodrich JA; Walker DI; He J; Lin X; Baumert BO; Hu X; Alderete TL; Chen Z; Valvi D; Fuentes ZC; Rock S; Wang H; Berhane K; Gilliland FD; Goran MI; Jones DP; Conti DV; Chatzi L
    Environ Health Perspect; 2023 Feb; 131(2):27005. PubMed ID: 36821578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).
    Park SK; Wang X; Ding N; Karvonen-Gutierrez CA; Calafat AM; Herman WH; Mukherjee B; Harlow SD
    Diabetologia; 2022 Jul; 65(7):1157-1168. PubMed ID: 35399113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the individual and combined toxicity of perfluoroalkyl substances to human liver cells using biomarkers of oxidative stress.
    Ojo AF; Xia Q; Peng C; Ng JC
    Chemosphere; 2021 Oct; 281():130808. PubMed ID: 34022600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.